Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | ($27.4M) | ($27.4M) | ($54.4M) | ($20.4M) | ($14.4M) | ($8,674.0K) | ($8,092.0K) | ($61.7M) | ($42.4M) | ($55.0M) | ($87.4M) | ($117.5M) | ($173.4M) | ($188.9M) | ($307.3M) | ($235.2M) | ($265.2M) | ($367.8M) | ($478.1M) | ($709.6M) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Insmed Incorporated's last 12-month Operating Income is ($734.3M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Insmed Incorporated's Operating Income growth was 5.8%. The average annual Operating Income growth rates for Insmed Incorporated have been 36.5% over the past three years, 21.6% over the past five years.
Over the last year, Insmed Incorporated's Operating Income growth was 5.8%, which is higher than industry growth of (0.1%). It indicates that Insmed Incorporated's Operating Income growth is Good.